Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TLR2 | O60603 | 3/20 | 0.54 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.54 |
| ▸ | MDM4 | O15151 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | KLK7 | P49862 | 1/20 | 0.46 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7392221 | 1.00 | MDM2 (0.57) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL7815145 | 1.00 | MDM2 (0.57) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL30441695 | 1.00 | MDM2 (0.57) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL17669898 | 1.00 | MDM2 (0.57) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL29400691 | 1.00 | MDM2 (0.57) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL2267346 | 0.97 | KMT2A (0.58) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL29401707 | 0.97 | KMT2A (0.58) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL12040103 | 0.97 | KMT2A (0.58) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL999302 | 0.97 | KMT2A (0.58) | MDM2KMT2ATLR2TLR1MDM4 | |
| SCHEMBL29362262 | 0.97 | KMT2A (0.58) | MDM2KMT2ATLR2TLR1MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634174-A1 | GONADOTROPIN-RELEASING HORMONE RECEPTOR (GNRHR) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4622966-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024129600-A1 | GONADOTROPIN-RELEASING HORMONE RECEPTOR (GNRHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024112612-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| EP-4069270-A1 | MODULATORS OF PROGRAMMED DEATH-LIGAND-1 AND/OR PROGRAMMED DEATH-LIGAND-2 | Southern Research Institute (US) | 2022-10-12 | — | — | EP | disclosed |